Head and Neck Diseases by Alexandros G.Sfakianakis: Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer

Τρίτη 21 Νοεμβρίου 2017

Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer

Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Biological: Nivolumab; Biological: Cetuximab; Drug: Placebo; Drug: Cisplatin
Sponsors: Bristol-Myers Squibb; ONO Pharmaceutical Co.
Not yet recruiting

http://ift.tt/2AkU2Ez

Head and Neck Diseases by Alexandros G.Sfakianakis

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Τρίτη 21 Νοεμβρίου 2017

Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου